Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke

NCT: NCT06440707 · RECRUITING

NCT IDNCT06440707
StatusRECRUITING
Start Date2025-07-15
Completion2030-08-01

Brief Summary

Many patients with acute ischemic stroke are ineligible for currently available standard treatments (clot-busting medication, also known as intravenous thrombolytic or mechanical removal of a clot), and many are non-responders, resulting in a low rate of excellent outcomes, which necessitates the development of novel therapies. In this study, investigators are testing a new treatment in which a weak electrical current will be applied via scalp electrodes to increase collateral blood flow to the brain and rescue the brain tissue at risk of injury. The primary aim is to find an optimal dose of this therapy that is both adequately safe and effective on imaging markers of brain tissue rescue.

Frequently Asked Questions

What is Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke?

Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke is a clinical trial registered under NCT06440707. Current status: RECRUITING.

What is the status of NCT06440707?

The current status of NCT06440707 (Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke) is: RECRUITING.

When did Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke start?

Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke started on 2025-07-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.